TEL AVIV (Reuters) - Teva Pharmaceutical Industries is optimistic the U.S. Supreme Court will decide in its favor regarding patent protection for Copaxone, its multiple sclerosis treatment, Chief Executive Erez Vigodman said on Thursday. Vigodman said in a conference call with analysts that he expects a decision by late this year or the first quarter of 2015. The court earlier this month appeared closely divided as it weighed Teva's high-profile fight with generic drug manufacturers over patent protections for its $4-billion-a-year drug. ...
via Health News Headlines - Yahoo News http://ift.tt/1vkj4FL
No comments:
Post a Comment